
Retrax S 250mg/125mg Injection
Marketer
Rezicure Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Retrax S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic prescribed for diverse bacterial infections. It combats microorganisms, halting their proliferation and infection spread. Administration must be overseen by a medical professional. Strictly adhere to the prescribed dosage schedule; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring via laboratory tests may be conducted to assess treatment response.
Primary Ingredients of Retrax S 250mg/125mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Retrax S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Retrax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Retrax S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Retrax S 250mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Retrax S 250mg/125mg Injection works:
The injectable formulation Retrax S (250mg Ceftriaxone/125mg Sulbactam) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thus hindering bacterial viability. Sulbactam, by counteracting beta-lactamase enzymes, amplifies Ceftriaxone's effectiveness and overcomes bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Retrax S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Retrax S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Retrax S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Retrax S 250mg/125mg Injection can potentially reduce awareness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Retrax S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Retrax S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Retrax S 250mg/125mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Retrax S 250mg/125mg Injection :
Should you forget a scheduled dose of Retrax S 250mg/125mg Injection, seek medical advice.
Facts to Know About Retrax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
